<DOC>
	<DOCNO>NCT00626717</DOCNO>
	<brief_summary>Background : Corneal cross link procedure induces collagen cross link corneal stroma due release reactive oxygen radical upon activation topically apply riboflavine A UVA exposure . This procedure might capable reduce keratocouns progression . Purpose : Although randomise controlled trial effectiveness corneal cross link treatment keratoconus gain importance general clinical setting . Therefore , investigator start randomise , placebo control , double blind , multicenter trial find treatment effective promise . Methods : Randomised , placebo control , double blind , multicenter trial .</brief_summary>
	<brief_title>Riboflavin Mediated Corneal Crosslinking Stabilizing Progression Keratoconus</brief_title>
	<detailed_description />
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<criteria>Only early Keratoconus ( Contact lens fit ) Progression Ametropia . Corneal thickness &gt; 450Âµm Further ophthalmic disease History ocular surgery Pregnancy , brest feed Allergy Riboflavin End stage Keratoconus</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Keratoconus</keyword>
	<keyword>Cross link</keyword>
	<keyword>Riboflavin</keyword>
</DOC>